SCHEMBL29253697

SCHEMBL29253697

C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)C)n2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 12/20 0.68
▸ EGFR P00533 11/20 0.68
▸ IGF1R P08069 11/20 0.62
▸ INSR P06213 10/20 0.62
▸ KCNH2 Q12809 1/20 0.61
▸ CHEK1 O14757 1/20 0.57
▸ AURKA O14965 1/20 0.57
▸ NUAK1 O60285 1/20 0.57
▸ JAK2 O60674 1/20 0.57
▸ STK10 O94804 1/20 0.57
▸ PRKD3 O94806 1/20 0.57
▸ SLC34A2 O95436 1/20 0.57
▸ CHEK2 O96017 1/20 0.57
▸ ABL1 P00519 1/20 0.57
▸ CD74 P04233 1/20 0.57
▸ ERBB2 P04626 1/20 0.57
▸ LCK P06239 1/20 0.57
▸ FYN P06241 1/20 0.57
▸ FES P07332 1/20 0.57
▸ CSF1R P07333 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21558123 0.97 EGFR (0.68) ALKEGFRIGF1RINSRKCNH2
SCHEMBL22520226 0.93 EGFR (0.58) ALKEGFRIGF1RINSRKCNH2
SCHEMBL25449395 0.92 ALK (0.61) ALKEGFRIGF1RINSRKCNH2
SCHEMBL29253608 0.92 EGFR (0.57) ALKEGFRIGF1RINSRKCNH2
SCHEMBL28649641 0.91 ALK (0.68) ALKEGFRIGF1RINSRKCNH2
SCHEMBL16780916 0.90 ALK (0.78) ALKEGFRIGF1RINSRCHEK1
SCHEMBL31196996 0.90 ALK (0.78) ALKEGFRIGF1RINSRCHEK1
SCHEMBL19027963 0.90 ALK (0.71) ALKEGFRIGF1RINSRKCNH2
SCHEMBL23248546 0.90 EGFR (0.72) ALKEGFRIGF1RINSR
SCHEMBL19027783 0.90 ALK (0.72) ALKEGFRIGF1RINSRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113677680-B EGFR inhibitor, composition and application thereof 贝达药业股份有限公司 2024-05-10 — — CN disclosed
Send feedback